Litigation Report: Texas Dominates as District Court Patent Filings Surge by 19% in 2025

Sterne Kessler Director Dennies Varughese discussed the trends in U.S. District Court patent filing data for 2025 in IAM’s Docket Navigator Litigation Report.

Varughese spoke about the absence of New Jersey in the data on summary judgment motions, which are not a feature of ANDA litigation. He explained, “ANDA litigation is at the intersection of patent laws, and food and drug laws. A generic company files an ANDA and a drug manufacturer gets a notice letter, creating a cause of action to sue them. There is no cause for a motion to dismiss. Almost every case meets the basic pleading requirement.